Augmedix Delivers 45 percent Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023
| AUGXDelisted Stock | USD 2.35 0.00 0.00% |
Slightly above 56% of Augmedix's investor base is looking to short. The analysis of current outlook of investing in Augmedix suggests that many traders are alarmed regarding Augmedix's prospects. Augmedix's investing sentiment can be driven by a variety of factors including economic data, Augmedix's earnings reports, geopolitical events, and overall market trends.
Augmedix |
SAN FRANCISCO, March 18, 2024 -- Augmedix , a leader in ambient AI medical documentation and data solutions, today reported financial results for the three and 12 months ended December 31, 2023. The fourth quarter was a solid end to a strong year for Augmedix both operationally and financially, stated Augmedix CEO Manny Krakaris. We delivered a 45 percent increase in revenue to 12.7 million, ahead of our most recent guidance, driven by a 44 percent increase in clinicians in
Read at finance.yahoo.com
 |
Augmedix Fundamental Analysis
We analyze Augmedix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Augmedix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Augmedix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Augmedix is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Augmedix Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Augmedix stock to make a market-neutral strategy. Peer analysis of Augmedix could also be used in its relative valuation, which is a method of valuing Augmedix by comparing valuation metrics with similar companies.
Peers
Augmedix Related Equities
| ACON | Aclarion | 5.88 | ||||
| ELEV | Elevation Oncology | 0.89 | ||||
| DRMA | Dermata Therapeutics | 4.35 | ||||
| INAB | In8bio | 4.45 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |